Dengue and COVID-19

  • During COVID-19 pandemic, the vector borne disease outbreaks of Dengue are likely to worsen health outcomes if they co-exist due to the compounded effect of haemorrhagic and cytokine response. This is of a bigger concern in endemic areas for Dengue, Malaria, etc when the population faces two simultaneous outbreaks of COVID-19 and the seasonal Dengue outbreak
  • The global incidence of dengue has grown dramatically in recent decades. About half of the world's population is now at risk.
  • The virus responsible for causing dengue, is called dengue virus (DENV). There are four DENV serotypes, meaning that it is possible to be infected four times
  • India contributes to about one thirds of all the estimated dengue cases in the world
  • There is no specific treatment for dengue/severe dengue. Early detection of disease progression associated with severe dengue, and access to proper medical care lowers fatality rates of severe dengue to below 1%.